Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.
|Translated title of the contribution||Clinical Impact and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions|
|Pages (from-to)||437 - 444|
|Number of pages||8|
|Journal||American Journal of Respiratory and Critical Care Medicine|
|Publication status||Published - Sep 2009|